Table 2.

Patient demographic characteristics

Patient ID no.SexAge, yEthnicityRaceDiagnosisType of transplantR/D CMV serostatusNo. of infusionsDays posttransplant
3910Male12Non-HispanicAfrican AmericanSickle cell anemiaMRDNegative/positive161
3944Female45HispanicWhiteAMLUCBPositive/negative1197
3976Male13HispanicWhiteALLMUDPositive/positive246
3762Female10HispanicWhiteHLHMMUDPositive/negative1161
3967Male51Non-HispanicWhiteAMLUCBPositive/negative1365
4091Male70Non-HispanicWhiteCTCLHaploPositive/positive1215
4115Female3Non-HispanicWhiteFanconi anemiaMUDPositive/positive1105
4170Male3Non-HispanicAfrican AmericanSickle cell anemiaMRDNegative/positive176
4134Female16Non-HispanicWhiteSCIDMUDPositive/positive1218
4201Male11Non-HispanicWhiteAnaplastic large-cell lymphomaMUDPositive/negative370
  • ALL, acute lymphoblastic leukemia; AML, acute myeloid leukemia; CTCL, cutaneous T-cell lymphoma; Haplo, haploidentical; HLH, hemophagocytic lymphohistiocytosis; MMUD, mismatched unrelated donor; MUD, matched unrelated donor; MRD, matched related donor; R/D, recipient/donor; SCID, severe combined immunodeficiency; UCB, umbilical cord blood.